Verve Therapeutics, Inc.

Verve Therapeutics, Inc.

Verve Therapeutics, Inc.

Overview
Date Founded

2018

Headquarters

26 Landsdowne Street,1st Floor,Cambridge, MA 02139

Type of Company

Private

Employees (Worldwide)

1 - 10

Industries

Other Business & Consulting Services
Biotechnology
Holding Companies

Company Description

Verve Therapeutics, Inc. is a bio technology company, which focuses to protect the world from heart disease. It researches, develops and manufactures cardiology & genetic medicines. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan, and Burt A. Adelman and is headquartered in Cambridge, MA.

Executives & Employees

Co-Founder

Co-Founder

Co-Founder

Co-Founder

Co-Founder

Co-Founder

President & Chief Operating Officer

Board of Directors

Co-Founder at Verve Therapeutics, Inc.

Venture Partner at ARCH Venture Partners

Managing Partner at Google Ventures

Chief Data Officer at The Broad Institute, Inc.

Co-Founder at Verve Therapeutics, Inc.

Co-Founder at Verve Therapeutics, Inc.

Scientific Adviser at bgC3 LLC

Principal at F-Prime Capital Partners

Paths to Verve Therapeutics, Inc.
Potential Connections via
Relationship Science
You
Verve Therapeutics, Inc.
Investors
Details Hidden

Redmile Group LLC /Private Equity/ is a private equity firm located in the US. The firm targets companies operating in the fields of technology. It provides financing for buyout transactions.

Details Hidden

Cormorant invests in companies primarily located in North America. The firm targets companies in sectors such as life-science and biotech. It provides financing for early stage capital requirements.

Details Hidden

Surveyor Capital employs a market-neutral investment framework that focuses on increasing the returns from specific stock selections and decreasing the return from broader market movement. The strategy requires a strong understanding of individual companies, as it seeks to remove the effect on returns from movement in the general equity market. Similar to large mutual funds, Surveyor Capital’s investment teams seek to form a deep understanding of each company’s strategy, management team, drivers of performance and cyclical and secular industry trends. The teams’ models typically take a 3+ year view of company prospects.In order to diversify risk and capture alpha in over 1,500 covered stocks, several independent sector-focused teams within Surveyor Capital conduct detailed fundamental research through a market-neutral investing framework. Investment decisions for each team are made by a portfolio manager based upon the research and recommendations of analysts and which are generally based on long-term views of each company. Portfolio managers use bottom-up, fundamental analysis when selecting the purchase or sale of stocks in their portfolios. The analysts and associates on each team have deep industry knowledge and conduct comprehensive research in order to identify attractive investment opportunities within their coverage universe. Each Surveyor Capital analyst covers 30-50 defined stocks with incremental capacity depending on the size of their supporting team. Portfolio managers overweight or underweight individual stocks relative to other stocks in the sector.

Suppliers
Beam Therapeutics, Inc. Biotechnology | Cambridge, MA

Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Verve Therapeutics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Verve Therapeutics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Verve Therapeutics, Inc..